Compare
Bone Biologics Corp vs NutriBand Inc. vs Regentis Biomaterials Ltd. vs Milestone Scientific Inc.
| Latest fiscal year | Bone Biologics Corp BBLG | NutriBand Inc. NTRB | Regentis Biomaterials Ltd. RGNT | Milestone Scientific Inc. MLSS |
|---|---|---|---|---|
| Year ended | 2025-12-31 | 2026-01-31 | 2025-12-31 | 2025-12-31 |
| Revenue | n/a | $2.04M | n/a | $8.97M |
| Revenue growth (YoY) | n/a | -4.8% | n/a | +4.0% |
| Gross margin | n/a | 27.8% (computed) | n/a | 71.4% |
| Operating margin | n/a | -408.4% | n/a | -63.5% |
| Net margin | n/a | -404.1% | n/a | -63.8% |
| Net income | -$3.11M | -$8.23M | -$13.65M | -$5.72M |
| EPS (Diluted) | -$2.65 | -$2.58 | -$24.16 | -$0.07 |
| Operating cash flow | -$2.69M | -$5.13M | -$1.38M | -$2.92M |
| Free cash flow | n/a | -$5.14M | n/a | -$2.93M |
| Cash & equivalents | n/a | $4.57M | $7.38M | $1.11M |
| Total assets | $5.80M | $7.55M | $7.62M | $7.81M |
| Total liabilities | $418.6K | $868.4K | $2.87M | $4.99M |
| Shareholders' equity | $5.38M | $6.68M | $4.74M | $2.81M |
| Return on year-end equity | -57.8% | -123.2% | -287.7% | -203.4% |
| Shares outstanding | 1.80M | 12.16M | 5.18M | 80.45M |
Revenue, most recent five fiscal years
| Fiscal year | Bone Biologics Corp | NutriBand Inc. | Regentis Biomaterials Ltd. | Milestone Scientific Inc. |
|---|---|---|---|---|
| Latest | $1.07B Ended 2020-12-31 | $2.04M Ended 2026-01-31 | n/a | $8.97M Ended 2025-12-31 |
| 1 year earlier | $1.07B Ended 2019-12-31 | $2.14M Ended 2025-01-31 | n/a | $8.63M Ended 2024-12-31 |
| 2 years earlier | n/a | $2.09M Ended 2024-01-31 | n/a | $9.83M Ended 2023-12-31 |
| 3 years earlier | n/a | $2.08M Ended 2023-01-31 | n/a | $8.81M Ended 2022-12-31 |
| 4 years earlier | n/a | $1.42M Ended 2022-01-31 | n/a | $10.30M Ended 2021-12-31 |